Consensus Guidelines from the International Ileal Pouch Consortium (please consider forwarding to your GI specialist)

For those of you who like to read into your condition, I wanted to share this exciting development.

Data for J-pouch related management, concerns, surveillance, etc have been sparse due to lack of numbers / co-ordination. It seems like Dr. Shen and colleagues have developed an international experts group and have started publishing consensus guidelines for management.

I wanted to share this so that you guys could forward to your GI specialists so that everyone is on the same page regarding best practices!

https://www.researchgate.net/p...eal_Pouch_Consortium

12/30/215:41 PM

❤️ 1

Original Post

Replies sorted oldest to newest

ytcrockpotMember

Thanks for the link, my gastro doc is one of the 37 Authors

12/31/2112:26 AM

❤️ 0

jan15Member

Thanks for the heads up. Good info.

For others out there who like to learn more about our conditions, and how to manage them, Columbia will have its second IBD symposium next week. Below is posted the link to register (do so as a patient) and a description. Get back to me if you have any questions and please if you attend and have comments either send them to me or--better yet--fill out the evaluation form. I thought the first one was excellent! Jan

Program Overview

Inflammatory bowel diseases (IBD) consist of two primary phenotypes, Crohn’s disease (CD) and ulcerative colitis (UC). Despite advances in medical treatment in IBD, disease-associated or IBD surgery-associated complications (such as strictures and fistulas) are common. Interventional IBD or therapeutic endoscopy has an expanding role in the treatment of disease and surgical complications. Endoscopic therapy offers more effective than medical treatment and less invasive than surgery, for the management of IBD-associated structural complications. Endoscopic therapy has been explored and used in the management of strictures, fistulas/abscesses, colitis-associated neoplasia, and post-surgical acute or chronic leaks, and obstructions. The endoscopic therapeutic modalities include balloon dilation, stricturotomy, stricturoplasty, stent placement, fistulotomy, fistula injection and clipping, sinusotomy, endoscopic mucosal resection, and endoscopic submucosal dissection. With a better understanding of the disease course of IBD, improved long-term impact of medical therapy, and advances in endoscopic technology, we can foresee interventional IBD will become an integrated part of the multidisciplinary approach for patients with complex IBD. This is a joint venture of Columbia University Irving Medical Center, NewYork Presbyterian Hospital, and the Global Interventional IBD Group. This CME-accreted conference will use “the Columbia Interventional IBD Symposium” as a logo from now on. It will run a full-day Zoom-based conference on January 14-15, 2022.

Learning Objectives

Discuss familiarity with the current status of biological therapy in IBD
Define principles, indications, techniques, and outcomes of endoscopic therapy for strictures, fistulae, and surgical leaks in IBD
Identify familiar with principles, diagnosis, and management of colitis-associated neoplasia in IBD
Discuss familiarity with rescue strategies for endoscopy-associated complications

1/5/223:04 PM

❤️ 0

Skip to main content

Add Reply

Membership Required

Remove From Your Block List

Manage Follow Preferences

Block

Please wait...